These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 34095878)

  • 1. Diverse immune response of DNA damage repair-deficient tumors.
    Qing T; Jun T; Lindblad KE; Lujambio A; Marczyk M; Pusztai L; Huang KL
    Cell Rep Med; 2021 May; 2(5):100276. PubMed ID: 34095878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between DNA damage repair gene somatic mutations and immune-related gene expression in ovarian cancer.
    Tian W; Shan B; Zhang Y; Ren Y; Liang S; Zhao J; Zhao Z; Wang G; Zhao X; Peng D; Bi R; Cai S; Bai Y; Wang H
    Cancer Med; 2020 Mar; 9(6):2190-2200. PubMed ID: 31991061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of DNA Damage Response Gene Alterations and Tumor Mutational Burden Across 17,486 Tubular Gastrointestinal Carcinomas: Implications for Therapy.
    Parikh AR; He Y; Hong TS; Corcoran RB; Clark JW; Ryan DP; Zou L; Ting DT; Catenacci DV; Chao J; Fakih M; Klempner SJ; Ross JS; Frampton GM; Miller VA; Ali SM; Schrock AB
    Oncologist; 2019 Oct; 24(10):1340-1347. PubMed ID: 31040255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting DNA damage response and repair genes to enhance anticancer immunotherapy: rationale and clinical implication.
    Lamberti G; Andrini E; Sisi M; Federico AD; Ricciuti B
    Future Oncol; 2020 Aug; 16(23):1751-1766. PubMed ID: 32539551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Function and Molecular Mechanism of the DNA Damage Response in Immunity and Cancer Immunotherapy.
    Ye Z; Shi Y; Lees-Miller SP; Tainer JA
    Front Immunol; 2021; 12():797880. PubMed ID: 34970273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA damage repair pathway alterations in metastatic clear cell renal cell carcinoma and implications on systemic therapy.
    Ged Y; Chaim JL; DiNatale RG; Knezevic A; Kotecha RR; Carlo MI; Lee CH; Foster A; Feldman DR; Teo MY; Iyer G; Chan T; Patil S; Motzer RJ; Hakimi AA; Voss MH
    J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32571992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Landscape of DNA damage response gene alterations in breast cancer: A comprehensive investigation.
    Jin J; Cao J; Li B; Li T; Zhang J; Cao J; Zhao M; Wang L; Wang B; Tao Z; Hu X
    Cancer; 2023 Mar; 129(6):845-859. PubMed ID: 36655350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in DNA damage response pathways as a potential biomarker for immune checkpoint blockade efficacy: evidence from a seven-cancer immunotherapy cohort.
    Zhang W; Zhang L; Jiang H; Li Y; Wang S; Wang Q
    Aging (Albany NY); 2021 Nov; 13(21):24136-24154. PubMed ID: 34747718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The complementarity of DDR, nucleic acids and anti-tumour immunity.
    Kornepati AVR; Rogers CM; Sung P; Curiel TJ
    Nature; 2023 Jul; 619(7970):475-486. PubMed ID: 37468584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-Level DNA Damage Repair Pathway Profiles and Anti-Tumor Immunity for Gastric Cancer.
    Lou S; Wang Y; Zhang J; Yin X; Zhang Y; Wang Y; Xue Y
    Front Immunol; 2021; 12():806324. PubMed ID: 35082793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA Damage and Repair Biomarkers of Immunotherapy Response.
    Mouw KW; Goldberg MS; Konstantinopoulos PA; D'Andrea AD
    Cancer Discov; 2017 Jul; 7(7):675-693. PubMed ID: 28630051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA damage repair gene mutations and their association with tumor immune regulatory gene expression in muscle invasive bladder cancer subtypes.
    Vidotto T; Nersesian S; Graham C; Siemens DR; Koti M
    J Immunother Cancer; 2019 Jun; 7(1):148. PubMed ID: 31174611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in DNA damage response and repair genes as potential biomarkers for immune checkpoint blockade in gastrointestinal cancer.
    Wang Y; Jiao X; Li S; Chen H; Wei X; Liu C; Gong J; Zhang X; Wang X; Peng Z; Qi C; Wang Z; Wang Y; Zhuo N; Zou J; Zhang H; Li J; Shen L; Lu Z
    Cancer Biol Med; 2021 Sep; 19(8):1139-49. PubMed ID: 34570439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA damage response and neoantigens: A favorable target for triple-negative breast cancer immunotherapy and vaccine development.
    Subbarayan R; Srinivasan D; Balakrishnan R; Kumar A; Usmani SS; Srivastava N
    Int Rev Cell Mol Biol; 2024; 389():104-152. PubMed ID: 39396845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germline DNA damage response gene mutations as predictive biomarkers of immune checkpoint inhibitor efficacy.
    Dennis MJ; Bylsma S; Madlensky L; Pagadala MS; Carter H; Patel SP
    Front Immunol; 2024; 15():1322187. PubMed ID: 38348036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of DNA Damage Response and Repair (DDR) Gene Mutations on Efficacy of PD-(L)1 Immune Checkpoint Inhibition in Non-Small Cell Lung Cancer.
    Ricciuti B; Recondo G; Spurr LF; Li YY; Lamberti G; Venkatraman D; Umeton R; Cherniack AD; Nishino M; Sholl LM; Shapiro GI; Awad MM; Cheng ML
    Clin Cancer Res; 2020 Aug; 26(15):4135-4142. PubMed ID: 32332016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting DNA Damage Response and Immune Checkpoint for Anticancer Therapy.
    Huang JL; Chang YT; Hong ZY; Lin CS
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RB1 and TP53 co-mutations correlate strongly with genomic biomarkers of response to immunity checkpoint inhibitors in urothelial bladder cancer.
    Manzano RG; Catalan-Latorre A; Brugarolas A
    BMC Cancer; 2021 Apr; 21(1):432. PubMed ID: 33879103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of mutations in DNA damage repair pathway gene in Chinese patients with hepatocellular carcinoma.
    Li J; Li N; Azhar MS; Liu L; Wang L; Zhang Q; Sheng L; Wang J; Feng S; Qiu Q; Xiao Y
    Sci Rep; 2022 Jul; 12(1):12330. PubMed ID: 35853969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of DNA damage repair defects on response to radium-223 and overall survival in metastatic castration-resistant prostate cancer.
    van der Doelen MJ; Isaacsson Velho P; Slootbeek PHJ; Pamidimarri Naga S; Bormann M; van Helvert S; Kroeze LI; van Oort IM; Gerritsen WR; Antonarakis ES; Mehra N
    Eur J Cancer; 2020 Sep; 136():16-24. PubMed ID: 32634759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.